Methimazole-Associated Neutropenia and Agranulocytosis in Pediatric Patients with Graves’ Disease: A Chinese Cohort Study
Thyroid® · 2026
DOI: 10.1177/10507256261472376 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Thyroid®, 2026. Verfasst von Shi Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China. Hauptthemen laut MEDLINE: Methimazole, Graves Disease, Neutropenia, Agranulocytosis. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Chinese National Natural Science Foundation Grants, Liaoning Provincial Department of Education Basic University Research Project-Young Scientist Science and Technology Innovation Team Project, Key Support Projects of the 2023 Funding for the High-Quality Development of China Medical University by the Liaoning Provincial Department of Science and Tech….
Abstract (Originalsprache)
Background
Graves’ disease (GD) is rare in children, and methimazole (MMI) is recommended as the first-line therapy. However, data on MMI-associated neutropenia and agranulocytosis in pediatric patients remain limited. In this study, we aimed to characterize the clinical features of these adverse events and to identify their associated risk factors.
Methods
A cohort study was conducted involving 432 pediatric patients with GD treated with MMI. Clinical and biochemical data were collected retrospectively and prospectively, with follow-up 0.5, 1, 2, 3, 4, 5, 6, 7–9, and 10–12 months after treatment initiation. Multivariable logistic regression analysis was performed to identify risk factors for MMI-associated neutropenia.
Results
During the 12-month follow-up period, 104 (24.1%) patients developed neutropenia, with 84.6% developing neutropenia within the first 3 months, 72.1% within 1 month, and 59.6% within 2 weeks. Among the affected patients, 83.7%, 13.5%, and 2.8% had mild, moderate, and severe neutropenia (agranulocytosis), respectively. All patients with moderate or severe neutropenia were asymptomatic and were identified through routine monitoring within the first month. Multivariable analysis revealed that a thyroid peroxidase antibody (TPOAb)-negative status (odds ratio [OR], 2.020; confidence interval [CI], 1.113–3.666) was associated with a higher prevalence of MMI-associated neutropenia, whereas older age (OR, 0.916; CI, 0.848–0.989) and higher baseline absolute neutrophil count (ANC; OR, 0.775; CI, 0.665–0.903) were protective factors.
Conclusions
ANC monitoring is recommended every 1 to 2 weeks during the first month and monthly for the first 3 months after MMI initiation. Pediatric patients with GD younger than 3 years with TPOAb-negative status or a baseline ANC < 3 × 10 9 /L may have a higher prevalence of MMI-associated neutropenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
- Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission Key Laboratory of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, People's Republ…
- Department of Endocrinology, Liaoyang Diabetes Hospital, Liaoyang, People's Republic of China.
ORCID-Profile: Shi Tang
Förderung
- Chinese National Natural Science Foundation Grants
- Liaoning Provincial Department of Education Basic University Research Project-Young Scientist Science and Technology Innovation Team Project
- Key Support Projects of the 2023 Funding for the High-Quality Development of China Medical University by the Liaoning Provincial Department of Science and Tech…
Zitieren
APA
Tang, S., Zhang, F., Zhu, W., Yang, M., Gong, M., Dang, P., Jiang, R., Lu, H., Xin, Y., & Teng, X. (2026). Methimazole-Associated Neutropenia and Agranulocytosis in Pediatric Patients with Graves’ Disease: A Chinese Cohort Study. Thyroid®. https://doi.org/10.1177/10507256261472376
Vancouver
Tang S, Zhang F, Zhu W, Yang M, Gong M, Dang P, et al. Methimazole-Associated Neutropenia and Agranulocytosis in Pediatric Patients with Graves’ Disease: A Chinese Cohort Study. Thyroid®. 2026. doi:10.1177/10507256261472376
BibTeX
@article{Tang2026,
author = {Tang, Shi and Zhang, Fang and Zhu, Wanhong and Yang, Min and Gong, Ming and Dang, Pingping and Jiang, Ranhua and Lu, He and Xin, Ying and Teng, Xiaochun},
title = {Methimazole-Associated Neutropenia and Agranulocytosis in Pediatric Patients with Graves’ Disease: A Chinese Cohort Study},
journal = {Thyroid®},
year = {2026},
doi = {10.1177/10507256261472376}
}
EUVIMED